Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Characterization of Acid Phosphatase in the Promastigotes of Three Isolates of Leishmania Major



Baghaei M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Parasitology, School of Medicine, Isfahan Univ. of Medical Sciences, Isfahan, Iran

Source: Iranian Journal of Medical Sciences Published:2003

Abstract

Background: Acid phosphatase (ACP) is suggested to be one of the virulence factors in leishmania and a correlation has been reported between Leishmanial acid phosphatase (ACP) activity and the severity of the disease in all types of leishmaniasis including zoonotic cutaneous leishmaniasis (ZCL), which is a polymorphic disease. Objective: Characterization of leishmania and its correlation with the severity of the skin lesions in zoonotic cutaneous leishmaniasis. Methods: Promastigotes were isolated from 30 patients with scaly flat ulcers (LP1), volcano-shaped lesions (LP2) and papular forms (LP3) of ZCL. The Km and Vmax values of ACP in the supernatant of lysed promastigotes were calculated in presence and absence of the enzyme inhibitors, fluoride, tartarate, phosphate and salicylate. Results: The Michaelis-Menten substrate saturation kinetics exhibited Km values of 12.5, 16.0, 26. 6 μM and Vmax values of 8.78, 5.26 and 1.51 μM/min/mg protein for LP1, LP2 and LP3, respectively. In all isolates, the ACP was inhibited by all four inhibitors but the percentage inhibition was different and each inhibitor showed a particular inhibition pattern for each promastigote preparation. ACP content of LP1 was more sensitive to all four inhibitors and fluoride was more potent inhibitor of the enzyme in three isolates. Conclusion: The differences in ACP kinetics may be interpreted as being consistent with the severity of the skin lesions in Leishmania major infection.
Related Docs
View other Related Docs
1. Bacterial Superinfection in Zoonotic Cutaneous Leishmaniasis, Medical Science Monitor (2012)
2. Enzymatic Characterization of Acid Phosphatase in the Logarithmic and Stationary Phase of Leishmania Major Promastigotes, Shiraz E Medical Journal (2015)
3. The Effect of Medium in Properties and Activity of Acid Phosphatase (Acp) in the Infective Form of Leishmania Major Promastigotes, Journal of Isfahan Medical School (2014)
4. Comparison of Protein Profile of Killed and Autoclaved Leishmania Major Using Polyacrylamide Gel Electrophoresis, Journal of Isfahan Medical School (2013)
5. Evaluation of Expression Variations in Virulence-Related Genes of Leishmania Major After Several Culture Passages Compared With Phlebotomus Papatasi Isolated Promastigotes, PLoS ONE (2023)
6. Intraspecific Variation in Leishmania Major Isolated From Different Forms of Zoonotic Cutaneous Leishmaniasis, Iranian Journal of Medical Sciences (2005)
7. Distribution Frequency of Pathogenic Bacteria Isolated From Cutaneus Leishmaniasis Lesions, Korean Journal of Parasitology (2008)
8. Identification and Isolation of the Cause of Cutaneous Leishmaniasis in Isfahan Using Its-Pcr Method, Journal of Isfahan Medical School (2012)
Experts (# of related papers)
View all Related Experts
Seyed Hossein Hejazi (69)
Sedighe Saberi (13)
Other Related Docs
9. Immunization Against Leishmania Major Using Uv-Irradiated Promastigote in Experimental Model Balb/C Mice, Biochemical and Cellular Archives (2017)
10. In Vitro Assessment of Dracocephalum Lindbergii for Growth Inhibition, Apoptosis Induction, and Cytokine Modulation Against Leishmania Major, Heliyon (2024)
11. Preparation and Characterization of Itraconazole Loaded Nanomicelles Based on Dextran–Behenic Acid for Cutaneous Leishmaniasis Treatment, Drug Development and Industrial Pharmacy (2021)
12. Identification and Isolation of the Cause of Cutaneous Leishmaniasis in Isfahan Using Its-Pcr Method, Journal of Isfahan Medical School (2012)
13. Genetic Polymorphism of Leishmania Major in Two Hyper Endemic Regions of Iran Revealed by Ppip-Pcr and Its- Rflp, Archives of Iranian Medicine (2012)
14. Visceral Leishmaniasis in a Patient With Cutaneous Lesions, Negative Leishman-Donovan Bodies and Immunological Test: A Case Report, Journal of Research in Medical Sciences (2011)
15. Treatment of Recurrent Cutaneous Leishmaniasis, International Journal of Dermatology (1995)
16. Evaluation of Different Concentrations of Imatinib on the Viability of Leishmania Major: An in Vitro Study, Advanced Biomedical Research (2019)
17. Investigating in Vitro Anti-Leishmanial Effects of Silibinin and Silymarin on Leishmania Major, Annals of parasitology (2018)
18. Comparison of Three Different Therapies for Cutaneous Leishmaniasis and Identification of the Etiologic Isolates in Isfahan, Iran, Archives of Iranian Medicine (2020)
19. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Itraconazole in the Treatment of Cutaneous Leishmaniasis, Journal of the European Academy of Dermatology and Venereology (2005)
20. The Molecular Epidemiology of Crithidia Strains in Isfahan City and Surrounding Areas, Iran, Journal of Isfahan Medical School (2014)
21. Clinical Picture of Cutaneous Leishmaniasis in Isfahan, Iran, International Journal of Dermatology (1994)
22. Isolation of Bacteria Causing Secondary Bacterial Infection in the Lesions of Cutaneous Leishmaniasis, Indian Journal of Dermatology (2008)
23. Comparative Molecular Epidemiology of Leishmania Major and Leishmania Tropica by Pcr-Rflp Technique in Hyper Endemic Cities of Isfahan and Bam, Iran, Medical Science Monitor (2010)
24. Evaluation of Leishmanin Skin Test Reaction in Different Variants of Cutaneous Leishmaniasis, Indian Journal of Dermatology (2013)
25. In Vitro Study of the Leishmanicidal Activity of Perovskia Abrotanoides Terpenoid-Rich Fractions Against Leishmania Major (Mrho/Ir/75/Er), Advanced Biomedical Research (2023)
26. Identification of Leishmania Isolates From Healing and Nonhealing Cutaneous Leishmaniasis Patients Using Internal Transcribed Spacer Region Pcr, Jundishapur Journal of Microbiology (2014)
27. The Study of the Inhibitory Effects of Aqueous and Ethanolic Extracts of Ziziphora Tenuior L. on the Proliferation of Leishmania Major Amastigotes, Iranian Journal of Dermatology (2018)
28. Molecular Identification and Phylogenetic Classification of Leishmania Spp. Isolated From Human Cutaneous Leishmaniasis in Iran: A Cross-Sectional Study, Iranian Journal of Parasitology (2018)
29. Comparative Molecular Epidemiology of Leishmania Major and Leishmania Tropica by Pcr-Rflp Technique in Hyper Endemic Cities of Isfahan and Bam, Iran, Case Reports and Clinical Practice Review (2010)
30. Recombinant C-Reactive Protein: A Potential Candidate for the Treatment of Cutaneous Leishmaniasis of Balb/C Mice Caused by Leishmania Major, Acta Parasitologica (2021)
31. Detection of Leishmania Parasites From Cutaneous Leishmaniasis Patients With Negative Direct Microscopy Using Nnn and Pcr-Rflp, Journal of Isfahan Medical School (2012)
32. Identification of Leishmania Species and Treatment Courses in Patients With Leishmaniasis in Isfahan, Iran, Journal of Isfahan Medical School (2012)
33. Aquaglyceroporin1 Gene Expression in Antimony Resistance and Susceptible Leishmania Major Isolates, Journal of Vector Borne Diseases (2016)
34. Pcr-Rflp Diagnosis and Characterization of Leishmania Species Causing Human Cutaneous Leishmaniasis and Evaluation of Treatment Times With Glucantime in These Patients, Tropical Biomedicine (2016)
35. Evaluation of the 11-Year Trend of Cutaneous Leishmaniasis in Six Main Foci of the Disease in Isfahan Province During the Years 2008 to 2018, Journal of Isfahan Medical School (2022)
36. Effects of S-Allyl-Cysteine on Survival, Apoptosis, and Proliferation of Leishmania Major in Vitro, Journal of Isfahan Medical School (2013)
37. In Vitro Anti-Leishmanial Activity of Satureja Hortensis and Artemisia Dracunculus Extracts on Leishmania Major Promastigotes, Journal of Parasitic Diseases (2016)
38. Topical Effectiveness of Different Concentrations of Nanosilver Solution on Leishmania Major Lesions in Balb/C Mice, Journal of Vector Borne Diseases (2012)
39. Serum Monocyte Chemotactic Protein-1 and Nitric Oxide in Cutaneous Leishmaniasis Patients Before and After Treatment With Glucantime, Journal of Isfahan Medical School (2012)
40. Cloning of Iranian Leishmania Major Mannose-1-Phosphate Guanyltransferase Gene, African Journal of Biotechnology (2009)
41. Epidemiological Aspects of Cutaneous Leishmaniasis in Iran, Archives of Clinical Infectious Diseases (2015)
42. Comparison of Intralesionally Injected Zinc Sulfate With Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis, Dermatology (2004)
43. Therapeutic Effect of Topical Tamoxifen in Murine Cutaneous Leishmaniasis Caused by Leishmania Major, Antimicrobial Agents and Chemotherapy (2024)
44. A Randomised, Double-Blind, Controlled Trial of a Killed L. Major Vaccine Plus Bcg Against Zoonotic Cutaneous Leishmaniasis in Iran, Vaccine (1999)
45. Combinatorial Delivery of Antigen and Tlr Agonists Via Plga Nanoparticles Modulates Leishmania Major-Infected-Macrophages Activation, Biomedicine and Pharmacotherapy (2021)
46. An Outbreak of Cutaneous Leishmaniasis Due to Leishmania Major in an Endemic Focus in Central Iran, Journal of Parasitic Diseases (2022)
47. Karyosystematic and Morphometric Characterization of the Rodents As Reservoir Hosts of Zoonotic Cutaneous Leishmaniasis in an Endemic Focus of Isfahan Province, Iran, Journal of Vector Borne Diseases (2009)
48. Nramp1 Gene Polymorphisms and Cutaneous Leishmaniasis: An Evaluation on Host Susceptibility and Treatment Outcome, Journal of Vector Borne Diseases (2016)
49. The Characterization and Antileishmanial Evaluation on Leishmania Major With Chitosan/Zno Bio-Nanocomposite As Drug Delivery Systems, Nanomedicine Research Journal (2022)
50. A Comparison of the Efficiency of Molecular and Conventional Methods in the Diagnosis of Cutaneous Leishmaniosis, Annals of parasitology (2021)